PROCF · Sofgen Pharma S.A.
Market Cap
$698,172
Shares
2.33B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 20-F | 2026-03-16 | 2024-12-31 | |
| 6-K | 2025-12-05 | — | |
| 6-K | 2025-11-19 | — | |
| 20-F | 2025-09-03 | 2023-12-31 | |
| 6-K | 2025-08-01 | — | |
| 6-K | 2025-07-14 | — | |
| 6-K | 2025-05-13 | — | |
| 6-K | 2025-04-14 | — | |
| 6-K | 2025-04-09 | — | |
| 6-K | 2025-03-25 | — | |
| 6-K | 2025-03-06 | — | |
| 6-K | 2025-02-19 | — | |
| 6-K | 2025-02-03 | — | |
| 6-K | 2025-01-21 | 2025-01-17 | |
| 6-K | 2025-01-16 | — | |
| 6-K | 2025-01-03 | — | |
| 6-K | 2024-12-31 | — | |
| 6-K | 2024-12-20 | — | |
| 6-K | 2024-12-03 | — | |
| 6-K | 2024-11-29 | — | |
| 6-K | 2024-11-15 | — | |
| 6-K | 2024-11-01 | — | |
| 6-K | 2024-10-10 | — | |
| 6-K | 2024-10-08 | — | |
| 6-K | 2024-09-18 | — | |
| 6-K | 2024-09-03 | — | |
| 6-K | 2024-08-26 | — | |
| 6-K | 2024-07-10 | — | |
| 6-K | 2024-06-28 | — | |
| 6-K | 2024-05-20 | — | |
| 6-K | 2024-05-14 | — | |
| 6-K | 2024-05-01 | — | |
| 6-K | 2024-03-04 | — | |
| 6-K | 2024-01-24 | 2024-01-23 | |
| 6-K | 2024-01-16 | — | |
| 6-K | 2024-01-05 | 2023-01-05 | |
| 6-K | 2023-12-26 | — | |
| 6-K | 2023-12-26 | — | |
| 6-K | 2023-11-22 | — | |
| 6-K | 2023-10-23 | — | |
| 6-K | 2023-09-07 | — | |
| 6-K | 2023-09-05 | — | |
| 6-K | 2023-09-05 | 2023-06-30 | |
| 6-K | 2023-08-21 | — | |
| 6-K | 2023-06-30 | — | |
| 6-K | 2023-06-14 | — | |
| 6-K | 2023-06-06 | 2023-06-05 | |
| 6-K | 2023-06-06 | 2023-06-05 | |
| 6-K | 2023-06-01 | — | |
| 6-K | 2023-05-15 | — |
Showing 1–50 of 89 filings